Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Kalinina, Tatyana ^a   Güngör, Cenap ^a   Thieltges, Sabrina ^a   Möller Krull, Maren ^a   Murga Penas, Eva M ^a   Wicklein, Daniel ^a   Streichert, Thomas ^a   Schumacher, Udo ^a   Kalinin, Viacheslav ^a   Simon, Ronald ^a   Otto, Benjamin ^a   Dierlamm, Judith ^a   Schwarzenbach, Heidi ^a   Effenberger, Katharina E ^a   Bockhorn, Maximilian ^a   Izbicki, Jakob R ^a   Yekebas, Emre F ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5; CELL ADHESION MOLECULE; CELL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; MUCIN 4; PROTEIN MEMO1; PROTEIN P53; PROTEIN RIOK3; RNA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 6; TRANSCRIPTION FACTOR GATA 6; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; PORE FORMING CYTOTOXIC PROTEIN; RAG2 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CARCINOMA CELL; CELL GROWTH; CELL STRUCTURE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; DRUG SENSITIVITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; LUNG METASTASIS; MALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PANCREAS ADENOCARCINOMA; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CULTURE TECHNIQUE; DNA MICROARRAY; DOSE RESPONSE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; METASTASIS; METHODOLOGY; MIDDLE AGED; MOUSE MUTANT; MUTATION; PANCREAS TUMOR; PATHOLOGY; TIME; TUMOR CELL LINE; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; PORE FORMING CYTOTOXIC PROTEINS; TIME FACTORS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953509415     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-295     Document Type: Article

References (55)

1. Kloppel G, Uttges J. The Pathology of ductal-type Pancreatic Carcinomas and Pancreatic Intraepithelial Neoplasia: Insights for Clinicians. Curr Gastroenter Rep 2004, 6:111-118.
2. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004, 363:1049-57. 10.1016/S0140-6736(04)15841-8, 15051286.
3. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002, 2:897-909. 10.1038/nrc949, 12459728.
4. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006, 20(10):1218-49. Review, 10.1101/gad.1415606, 16702400.
5. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001, 1(1):46-54. 10.1038/35094059, 11900251.
6. Bockhorn M, Cataldegirmen G, Kutup A, Marx A, Burdelski C, Vashist JK, Mann O, Liebl L, König A, Izbicki JR, Yekebas EF. Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability. Ann Surg Oncol 2009, 16(5):1212-21. 10.1245/s10434-009-0363-2, 19225843.
7. Kawano K, Iwamura T, Yamanari H, Seo Y, Suganuma T, Chijiiwa K. Establishment and characterization of a novel human pancreatic cancer cell line (SUIT-4)metastasizing to lymph nodes and lungs in nude mice. Oncology 2004, 66(6):458-67. 10.1159/000079500, 15452375.
8. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia. Br J Cancer 1998, 77:1-10.
9. Jojovic M, Schumacher U. Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer cells transplanted into SCID mice. Cancer Letters 2000, 152(2):151-156. 10.1016/S0304-3835(99)00443-7, 10773406.
10. Olshen AB, Venkatraman ES, Lucito R. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004, 5:557-572. 10.1093/biostatistics/kxh008, 15475419.
11. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JYH, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 2004, 5:R80. 545600, 15461798, 10.1186/gb-2004-5-10-r80.
12. Ulrich AB, Schmied BM, Standop J, Schneider MB, Pour PM. Pancreatic cell lines: a review. Pancreas 2002, 24(2):111-20. 10.1097/00006676-200203000-00001, 11854615.
13. Nardone M. Curbing rampant cross-contamination and misidentification of cell lines. Biotechniques 2008, 45:3.
14. Chatterjee R. Cases of mistaken identity. Science 2007, 315:928-931. 10.1126/science.315.5814.928, 17303729.
15. Dobrynin YV. Establishment and Characteristics of Cell strains from some Epithelial Tumors of Human Origin. J Natl Cancer Inst 1963, 31:1173-95.
16. Masters JRW, Palsson B. Cancer Cell Lines. Part I: Human Cell Culture 1998, 1:107-122. New York: Kluwer Academic.
17. Fogh J, Orfeo T, Tiso J, Sharkey FE, Fogh JM, Daniels WP. Twenty-three new human tumor lines established in nude mice. Exp Cell Biol 1980, 48(3):229-39.
18. Loukopoulos P, Kanetaka K, Takamura M, Shibata T, Sakamoto M, Hirohashi S. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displayed varying metastatic activity. Pancreas 2004, 29(3):193-203. 10.1097/00006676-200410000-00004, 15367885.
19. Capellá G, Farré L, Villanueva A, Reyes G, García C, Tarafa G, Lluís F. Orthotopic models of human pancreatic cancer. Ann N Y Acad Sci 1999, 30(880):103-9. Review.
20. Schumacher U, Adam E, Dietl J, Horny HP. Immunophenotype of human ovarian malignancies (cystadenocarcinomata and mixed müllerian tumor) established in SCID mice. Exp Mol Pathol 1997, 64(2):103-13. 10.1006/exmp.1997.2213, 9316588.
21. Kowalski J, Morsberger LA, Blackford A, Hawkins A, Yeo CJ, Hruban RH, Griffin CA. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes. Cancer Genetics and Cytogenetics 2007, 178(1):26-35.
22. Gorunova L, Höglund M, Andrén-Sandberg A, Dawiskiba S, Jin Y, Mitelman F, Johansson B. Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 1998, 23(2):81-99. 10.1002/(SICI)1098-2264(199810)23:2<81::AID-GCC1>3.0.CO;2-0, 9739011.
23. Sirivatanauksorn V, Sirivatanauksorn Y, Gorman PA, Davidson JM, Sheer D, Moore PS, Scarpa A, Edwards PA, Lemoine NR. Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping. Int J Cancer 2001, 91(3):350-8. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1049>3.3.CO;2-3, 11169959.
24. Karhu R, Mahlamaki E, Kallioniemi A. Pancreatic adenocarcinoma - genetic portrait from chromosomes to microarrays. Genes Chromosomes Cancer 2006, 45:721-730. 10.1002/gcc.20337, 16688744.
25. Griffin CA, Morsberger L, Hawkins AL, Haddadin M, Patel A, Ried T, Schrock E, Perlman EJ, Jaffee E. Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations. Cytogenet Genome Res 2007, 118:148-156. 10.1159/000108295, 18000365.
26. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1990, 50(4):1352.
27. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54:4855-78.
28. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994, 54(6):1556-60.
29. Brandt R, Grützmann R, Bauer A, Jesnowski R, Ringel J, Löhr M, Pilarsky C, Hoheisel JD. DNA microarray analysis of pancreatic malignancies. Pancreatology 2004, 4(6):587-97. 10.1159/000082241, 15557762.
30. Fu B, Luo M, Lakkur S, Lucito R, Iacobuzio-Donahue CA. Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma. Cancer Biology & Therapy 2008, 7:1593-601. 10.4161/cbt.7.10.6565, 18769116.
31. Kimmelman AC, Hezel AF, Aguirre AJ, Zheng H, Paik JH, Ying H, Chu GC, Zhang JX, Sahin E, Yeo G, Ponugoti A, Nabioullin R, Deroo S, Yang S, Wang X, McGrath JP, Protopopova M, Ivanova E, Zhang J, Feng B, Tsao MS, Redston M, Protopopov A, Xiao Y, Futreal PA, Hahn WC, Klimstra DS, Chin L, DePinho RA. Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci USA 2008, 105(49):19372-7. 2614768, 19050074, 10.1073/pnas.0809966105.
32. Marone R, Hess D, Dankort D, Muller WJ, Hynes NE, Badache A. Memo mediates ErbB2-driven cell motility. Nat Cell Biol 2004, 6(6):515-22. 10.1038/ncb1134, 15156151.
33. Korherr C, Gille H, Schäfer R, Koenig-Hoffmann K, Dixelius J, Egland KA, Pastan I, Brinkmann U. Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway. Proc Natl Acad Sci USA 2006, 103(11):4240-5. 1449677, 16537515, 10.1073/pnas.0511319103.
34. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase-AKT pathway in human cancer. Nature Reviews Cancer 2002, 2:489-501. 10.1038/nrc839, 12094235.
35. Brognard J, Clark AS, Ni Y, Dennis PA. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001, 61(10):3986-97.
36. West KA, Castillo SS, Dennis PA. Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 2002, 5(6):234-48. Review, 10.1016/S1368-7646(02)00120-6, 12531180.
37. Yamamoto S, Tomita Y, Hoshida Y, Morooka T, Nagano H, Dono K, Umeshita K, Sakon M, Ishikawa O, Ohigashi H, Nakamori S, Monden M, Aozasa K. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res 2004, 10(8):2846-50. 10.1158/1078-0432.CCR-02-1441, 15102693.
38. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 1996, 93(8):3636-41. 39663, 8622988, 10.1073/pnas.93.8.3636.
39. Gress TM, Müller-Pillasch F, Lerch MM, Friess H, Büchler M, Adler G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer 1995, 62(4):407-13. 10.1002/ijc.2910620409, 7635566.
40. Koshiba T, Hosotani R, Wada M, Miyamoto Y, Fujimoto K, Lee JU, Doi R, Arii S, Imamura M. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer 1998, 82:642-50. 10.1002/(SICI)1097-0142(19980215)82:4<642::AID-CNCR5>3.0.CO;2-N, 9477095.
41. Shi WD, Meng ZQ, Chen Z, Lin JH, Zhou ZH, Liu LM. Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis. Cancer Letters 2009, 283(1):84-91. 10.1016/j.canlet.2009.03.030, 19375852.
42. Chaturvedi P, Singh AP, Batra SK. Structure, evolution, and biology of the MUC4 mucin. FASEB J 2008, 4:966-81. Review.
43. Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL, Batra SK. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res 2007, 5(4):309-20. 10.1158/1541-7786.MCR-06-0353, 17406026.
44. Moniaux N, Andrianifahanana M, Brand RE, Batra SK. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. Br J Cancer 2004, 91(9):1633-8. Review, 2409950, 15494719.
45. Hruban RH, Goggins M, Parsons J, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res 2000, 6(8):2969-72. Review.
46. Hu YP, Haq B, Carraway KL, Savaraj N, Lampidis TJ. Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells. Biochem Pharmacol 2003, 65(9):1419-25. 10.1016/S0006-2952(03)00086-8, 12732353.
47. Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Büchler MW, Aubert JP, Batra SK. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 2001, 7(12):4033-40.
48. Blumenthal RD, Leon E, Hansen HJ, Goldenberg DM. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. BMC Cancer 2007, 7:2. 1769503, 17201906, 10.1186/1471-2407-7-2.
49. Hammarström S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999, 2:67-81. Review.
50. Blumenthal RD, Hansen HJ, Goldenberg DM. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res 2005, 65(19):8809-17. 10.1158/0008-5472.CAN-05-0420, 16204051.
51. Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness. Oncogene 2004, 23(34):5834-42. 10.1038/sj.onc.1207775, 15208677.
52. Ordoñez C, Screaton RA, Ilantzis C, Stanners CP. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res 2000, 60(13):3419-24.
53. Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res 2004, 64(11):3987-93. 10.1158/0008-5472.CAN-04-0424, 15173012.
54. Kollmannsberger C, Peters HD, Fink U. Chemotherapy in advanced pancreatic adenocarcinoma. Cancer Treat Rev 1998, 24(2):133-56. 10.1016/S0305-7372(98)90079-2, 9728423.
55. Burch PA, Ghosh C, Schroeder G, Allmer C, Woodhouse CL, Goldberg RM, Addo F, Bernath AM, Tschetter LK, Windschitl HE, Cobau CD. Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial. Am J Clin Oncol 2000, 23(5):534-7.